Tuberous Sclerosis Complex (TSC) is an autosomal dominant disease resulting from heterozygous pathologic variants in either TSC1 or TSC2. Present in approximately one in 5,800 individuals, TSC predisposes patients to a wide array of clinical features involving the skin, brain, kidneys, eyes, heart, and lungs. This evidence concerns the gene TSC2 and tuberous sclerosis.